OTC cough and congestion medication recalled for crystallization
Denison Pharmaceuticals is recalling its Maximum Strength Cough and Chest Congestion medication due to crystallization in bottles. The product, distributed by Genexa Inc., may contain chunks, graininess, or crystal substances that affect uniformity.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for a product quality defect involving crystallization that affects uniformity. No safety hazards or illnesses are explicitly described in the source. Class III recalls are typically assigned lower severity scores (1 or 2).
Plain-English summary
Denison Pharmaceuticals, LLC is recalling Maximum Strength Cough and Chest Congestion medication distributed by Genexa Inc. The recalled product consists of Kids' Cough and Chest Congestion (containing Dextromethorphan HBr 5mg and Guaifenesin 100mg) packaged in 4 oz bottles. A total of 105,048 bottles are affected.
The recall is due to crystallization in the product, resulting in a lack of uniformity, texture changes, and the appearance of small crystal substances inside the bottles. Affected lots include Lot #0813V (expiration 06/2025) and Lot #0103V (expiration 03/2025), with UPC code 850015736018.
The recalled product was distributed to two accounts that may have distributed the product further to retail locations.
The recalled product
- Product
- MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK (DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE)
- Brand
- MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK
- Manufacturer
- Denison Pharmaceuticals, LLC
- Category
- Drug — OTC Cough and Cold
- Hazard
- Affected units
- 105,048
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 0813V
- Exp 06/2025
- 0103V
- Exp 03/2025
UPCs (1)
- 850015736018
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Denison Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK
- LowOTC Cold and Cough Medication Recalled Due to Crystallization
FDA (Drugs) · 2024-11-13
Same manufacturer · Denison Pharmaceuticals, LLC
See all →- HighAcne treatment gel recalled for benzene contamination nationwide
FDA (Drugs) · 2025-03-19
- HighLittle Remedies Gas Relief Drops Class II Recall for Manufacturing Deviations
FDA (Drugs) · 2024-06-26
- HighCough medicine recalled due to manufacturing process deviation with non-food lubricant
FDA (Drugs) · 2023-06-07
- HighCough Relief Medication Recalled for Non-Food Grade Lubricant Manufacturing Defect
FDA (Drugs) · 2023-06-07
- HighPin-Away Pyrantel Pamoate Recalled for Non-Food-Grade Lubricant Use in Manufacturing
FDA (Drugs) · 2023-06-07
Same hazard · crystallization
See all →- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighBuprenorphine injection vials show crystallization identified as buprenorphine free base
FDA (Drugs) · 2026-06-24
- HighDapsone Topical Gel Recalled Due to Crystallization Defect
FDA (Drugs) · 2025-01-08
- ModerateDapsone Gel Recalled Nationwide for Crystallization
FDA (Drugs) · 2025-01-08
- ModerateDapsone Gel 7.5% recalled nationwide due to crystallization
FDA (Drugs) · 2024-11-13